Agilent Technologies, Inc. $A Shares Sold by Raiffeisen Bank International AG

Raiffeisen Bank International AG trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 7.7% in the third quarter, HoldingsChannel reports. The institutional investor owned 235,382 shares of the medical research company’s stock after selling 19,500 shares during the period. Raiffeisen Bank International AG’s holdings in Agilent Technologies were worth $29,129,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Capital A Wealth Management LLC grew its position in Agilent Technologies by 10,600.0% during the second quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares during the period. Davis Capital Management purchased a new position in shares of Agilent Technologies in the 3rd quarter worth about $28,000. Physician Wealth Advisors Inc. lifted its stake in shares of Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares in the last quarter. State of Wyoming acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at about $35,000. Finally, SJS Investment Consulting Inc. grew its holdings in shares of Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after purchasing an additional 312 shares during the period.

Insider Activity

In other news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Agilent Technologies Stock Performance

Shares of A stock opened at $122.92 on Friday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company’s fifty day moving average price is $136.17 and its two-hundred day moving average price is $135.61. The firm has a market capitalization of $34.77 billion, a P/E ratio of 26.90, a P/E/G ratio of 3.67 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same period last year, the firm earned $1.46 earnings per share. The company’s revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Bank of America lifted their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research report on Tuesday, November 25th. Barclays upgraded shares of Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 target price on the stock in a report on Monday, December 15th. Morgan Stanley started coverage on shares of Agilent Technologies in a research report on Tuesday, December 2nd. They set an “overweight” rating for the company. UBS Group raised their price objective on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Finally, The Goldman Sachs Group initiated coverage on Agilent Technologies in a research report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and an average target price of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.